Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Effect of IV alteplase on the ischemic brain lesion at 24-48 hours after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Sandercock PAG, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2018 Nov 27;91(22):e2067-e2077. doi: 10.1212/WNL.0000000000006575. Epub 2018 Oct 26.

2.

Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke.

Mair G, von Kummer R, Adami A, White PM, Adams ME, Yan B, Demchuk AM, Farrall AJ, Sellar RJ, Sakka E, Palmer J, Perry D, Lindley RI, Sandercock PA, Wardlaw JM; IST-3 Collaborative Group.

Stroke. 2017 Feb;48(2):353-360. doi: 10.1161/STROKEAHA.116.015164. Epub 2016 Dec 22.

3.

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study.

Bronstein MD, Fleseriu M, Neggers S, Colao A, Sheppard M, Gu F, Shen CC, Gadelha M, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Freda P; Pasireotide C2305 Study Group.

BMC Endocr Disord. 2016 Apr 2;16:16. doi: 10.1186/s12902-016-0096-8.

4.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.

5.

Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study.

Samarasekera N, Lerpiniere C, Fonville AF, Farrall AJ, Wardlaw JM, White PM, Torgersen A, Ironside JW, Smith C, Al-Shahi Salman R; Lothian Audit of the Treatment of Cerebral Haemorrhage (LATCH) collaborators.

PLoS One. 2015 Aug 24;10(8):e0135043. doi: 10.1371/journal.pone.0135043. eCollection 2015.

6.

Hemispheric association and dissociation of voice and speech information processing in stroke.

Jones AB, Farrall AJ, Belin P, Pernet CR.

Cortex. 2015 Oct;71:232-9. doi: 10.1016/j.cortex.2015.07.004. Epub 2015 Jul 16.

PMID:
26247409
7.

Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study.

Samarasekera N, Fonville A, Lerpiniere C, Farrall AJ, Wardlaw JM, White PM, Smith C, Al-Shahi Salman R; Lothian Audit of the Treatment of Cerebral Haemorrhage Collaborators.

Stroke. 2015 Feb;46(2):361-8. doi: 10.1161/STROKEAHA.114.007953. Epub 2015 Jan 13.

PMID:
25586833
8.

Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke Trial.

Mair G, von Kummer R, Adami A, White PM, Adams ME, Yan B, Demchuk AM, Farrall AJ, Sellar RJ, Ramaswamy R, Mollison D, Boyd EV, Rodrigues MA, Samji K, Baird AJ, Cohen G, Sakka E, Palmer J, Perry D, Lindley R, Sandercock PA, Wardlaw JM; IST-3 Collaborative Group.

Neuroradiology. 2015 Jan;57(1):1-9. doi: 10.1007/s00234-014-1441-0. Epub 2014 Oct 7.

9.

Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.

Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group.

J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13.

10.

CT and Clinical Predictors of Fatigue at One Month after Stroke.

Kutlubaev MA, Shenkin SD, Farrall AJ, Duncan FH, Lewis SJ, Greig CA, Dennis MS, Wardlaw JM, Maclullich AM, Mead GE.

Cerebrovasc Dis Extra. 2013 Mar 22;3(1):26-34. doi: 10.1159/000347113. eCollection 2013.

11.

Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study.

Petersenn S, Farrall AJ, De Block C, Melmed S, Schopohl J, Caron P, Cuneo R, Kleinberg D, Colao A, Ruffin M, Hermosillo Reséndiz K, Hughes G, Hu K, Barkan A.

Pituitary. 2014 Apr;17(2):132-40. doi: 10.1007/s11102-013-0478-0. Erratum in: Pituitary. 2014 Apr;17(2):141. Block, Christophe [corrected to De Block, Christophe].

12.

A large web-based observer reliability study of early ischaemic signs on computed tomography. The Acute Cerebral CT Evaluation of Stroke Study (ACCESS).

Wardlaw JM, von Kummer R, Farrall AJ, Chappell FM, Hill M, Perry D.

PLoS One. 2010 Dec 30;5(12):e15757. doi: 10.1371/journal.pone.0015757.

13.

Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities.

Armitage PA, Farrall AJ, Carpenter TK, Doubal FN, Wardlaw JM.

Magn Reson Imaging. 2011 Apr;29(3):305-14. doi: 10.1016/j.mri.2010.09.002. Epub 2010 Oct 27.

14.

Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial.

Petersenn S, Schopohl J, Barkan A, Mohideen P, Colao A, Abs R, Buchelt A, Ho YY, Hu K, Farrall AJ, Melmed S, Biller BM; Pasireotide Acromegaly Study Group.

J Clin Endocrinol Metab. 2010 Jun;95(6):2781-9. doi: 10.1210/jc.2009-2272. Epub 2010 Apr 21.

PMID:
20410233
15.

Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study.

Starr JM, Farrall AJ, Armitage P, McGurn B, Wardlaw J.

Psychiatry Res. 2009 Mar 31;171(3):232-41. doi: 10.1016/j.pscychresns.2008.04.003. Epub 2009 Feb 10.

PMID:
19211227
16.

Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study.

Colao A, Cappabianca P, Caron P, De Menis E, Farrall AJ, Gadelha MR, Hmissi A, Rees A, Reincke M, Safari M, T'Sjoen G, Bouterfa H, Cuneo RC.

Clin Endocrinol (Oxf). 2009 May;70(5):757-68. doi: 10.1111/j.1365-2265.2008.03441.x. Epub 2008 Oct 6.

PMID:
19178516
17.

Associations between diffusion and perfusion parameters, N-acetyl aspartate, and lactate in acute ischemic stroke.

Cvoro V, Wardlaw JM, Marshall I, Armitage PA, Rivers CS, Bastin ME, Carpenter TK, Wartolowska K, Farrall AJ, Dennis MS.

Stroke. 2009 Mar;40(3):767-72. doi: 10.1161/STROKEAHA.108.525626. Epub 2009 Jan 15.

PMID:
19150873
18.

Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

Farrall AJ, Wardlaw JM.

Neurobiol Aging. 2009 Mar;30(3):337-52. Epub 2007 Sep 14. Review.

PMID:
17869382
19.

A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.

Mercado M, Borges F, Bouterfa H, Chang TC, Chervin A, Farrall AJ, Patocs A, Petersenn S, Podoba J, Safari M, Wardlaw J; SMS995B2401 Study Group.

Clin Endocrinol (Oxf). 2007 Jun;66(6):859-68. Epub 2007 Apr 25.

20.

Factors influencing the detection of early CT signs of cerebral ischemia: an internet-based, international multiobserver study.

Wardlaw JM, Farrall AJ, Perry D, von Kummer R, Mielke O, Moulin T, Ciccone A, Hill M; Acute Cerebral CT Evaluation of Stroke Study (ACCESS) Study Group.

Stroke. 2007 Apr;38(4):1250-6. Epub 2007 Mar 8.

PMID:
17347470
21.

Temporal evolution of water diffusion parameters is different in grey and white matter in human ischaemic stroke.

Muñoz Maniega S, Bastin ME, Armitage PA, Farrall AJ, Carpenter TK, Hand PJ, Cvoro V, Rivers CS, Wardlaw JM.

J Neurol Neurosurg Psychiatry. 2004 Dec;75(12):1714-8.

22.

Diagnosis of stroke on neuroimaging.

Wardlaw JM, Farrall AJ.

BMJ. 2004 Mar 20;328(7441):655-6. No abstract available.

23.

Diffuse brain oedema in idiopathic intracranial hypertension: a quantitative magnetic resonance imaging study.

Bastin ME, Sinha S, Farrall AJ, Wardlaw JM, Whittle IR.

J Neurol Neurosurg Psychiatry. 2003 Dec;74(12):1693-6.

24.

Myocardial infarction in a canine model monitored by two-dimensional 31P chemical shift spectroscopic imaging.

Farrall AJ, Thompson RT, Wisenberg G, Campbell CM, Drost DJ.

Magn Reson Med. 1997 Oct;38(4):577-84.

PMID:
9324325

Supplemental Content

Loading ...
Support Center